{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:46Z","timestamp":1790096926470,"version":"4.0.1"},"reference-count":161,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Invasive candidiasis (IC) is a systemic life-threatening infection of immunocompromised humans, but remains a relatively neglected disease among public health authorities. Ongoing assessments of disease epidemiology are needed to identify and map trends of importance that may necessitate improvements in disease management and patient care. Well-established incidence increases, largely due to expanding populations of patients with pre-disposing risk factors, has led to increased clinical use and pressures on antifungal drugs. This has been exacerbated by a lack of fast, accurate diagnostics that have led treatment guidelines to often recommend preventative strategies in the absence of proven infection, resulting in unnecessary antifungal use in many instances. The consequences of this are multifactorial, but a contribution to emerging drug resistance is of primary concern, with high levels of antifungal use heavily implicated in global shifts to more resistant Candida strains. Preserving and expanding the utility and number of antifungals should therefore be of the highest priority. This may be achievable through the development and use of biomarker tests, bringing about a new era in improved antifungal stewardship, as well as novel antifungals that offer favorable profiles by targeting Candida pathogenesis mechanisms over cell viability.<\/jats:p>","DOI":"10.3390\/microorganisms10061208","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T22:00:38Z","timestamp":1655157638000},"page":"1208","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis"],"prefix":"10.3390","volume":"10","author":[{"given":"Ben Y.","family":"Parslow","sequence":"first","affiliation":[{"name":"Biosciences, College of Life and Environmental Sciences, Geoffrey Pope Building, University of Exeter, Stocker Road, Exeter EX4 4QD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-3130","authenticated-orcid":false,"given":"Christopher R.","family":"Thornton","sequence":"additional","affiliation":[{"name":"Medical Research Council Centre for Medical Mycology, Geoffrey Pope Building, University of Exeter, Stocker Road, Exeter EX4 4QD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"11","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: A persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e00449-20","DOI":"10.1128\/mBio.00449-20","article-title":"Threats posed by the fungal kingdom to humans, wildlife and agriculture","volume":"11","author":"Fischer","year":"2020","journal-title":"mBio"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","article-title":"Epidemiology and risk factors for invasive candidiasis","volume":"10","author":"Yapar","year":"2014","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and multi-national prevalence of fungal diseases\u2014Estimate precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-based active surveillance for culture confirmed candidemia\u2014Four sites, United States, 2012\u20132016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill. Summ."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/EC.2.5.1053-1060.2003","article-title":"Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection","volume":"2","author":"Saville","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1128\/AAC.01079-10","article-title":"Candida bloodstream infections: Comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008\u20132009","volume":"55","author":"Pfaller","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cmissing 50%\u201d of invasive candidiasis: How nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e01909-17","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID Guideline for the diagnosis and management of Candida diseases 2012: Non-neutropenic adult patients","volume":"7","author":"Cornely","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/jac\/dkx445","article-title":"What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead","volume":"73","author":"Bassetti","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: Selected new molecules and beyond","volume":"9","author":"Casadevall","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_16","first-page":"04112","article-title":"Risk factors for invasive candida infection in critically ill patients\u2014a systematic review and meta-analysis","volume":"21","author":"Schalttmann","year":"2021","journal-title":"Chest"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00134-014-3355-z","article-title":"Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later","volume":"40","author":"Eggimann","year":"2014","journal-title":"Intensive Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00134-005-2571-y","article-title":"Candida spp. colonization significance in critically ill medical patients: A prospective study","volume":"31","author":"Charles","year":"2015","journal-title":"Intensive Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/01.CCM.0000201897.78123.44","article-title":"Invasive candidiasis in the intensive care unit","volume":"34","author":"Pappas","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mib.2011.07.015","article-title":"Inflammation and gastrointestinal Candida colonization","volume":"14","author":"Kumamoto","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1038\/s41598-019-45467-7","article-title":"Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans","volume":"9","author":"Guinan","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40168-020-00899-6","article-title":"Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria","volume":"8","author":"Seelbinder","year":"2020","journal-title":"Microbiome"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Teoh, F., and Pavelka, N. (2016). How chemotherapy increases the risk of systemic candidiasis in cancer patients: Current paradigm and future directions. Pathogens, 5.","DOI":"10.3390\/pathogens5010006"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Rodrigues, C.F., Rodrigues, M.E., and Henriques, M. (2019). Candida spp. infections in patients with diabetes mellitus. J. Clin. Med., 8.","DOI":"10.3390\/jcm8010076"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/432060","article-title":"Emerging fungal diseases","volume":"41","author":"Nucci","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Boxer, L.A. (2012). How to Approach Neutropenia, Hematology, ASH Education Program.","DOI":"10.1182\/asheducation.V2012.1.174.3798251"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/13693780410001731619","article-title":"Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: Approach to developing practical criteria for systemic use in antifungal prophylaxis trials","volume":"43","author":"Paphitou","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/00365540701534509","article-title":"Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome","volume":"40","author":"Klingspor","year":"2008","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1439-0507.2007.01366.x","article-title":"Risk factors for candidemia in critically ill patients: A prospective surveillance study","volume":"50","author":"Jurado","year":"2007","journal-title":"Mycoses"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","article-title":"Invasive candidiasis","volume":"20","author":"Pappas","year":"2006","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1439-0507.2009.01691.x","article-title":"The changing face of epidemiology of invasive fungal disease in Europe","volume":"52","year":"2009","journal-title":"Mycoses"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cleaveland, A.A., Harrison, L.H., Farley, M.M., Hollick, R., Stein, B., Chiller, T.M., Lockhart, S.R., and Park, B.J. (2015). Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008\u20142013: Results from population-based surveillance. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120452"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JCM.06346-11","article-title":"Declining incidence of candidemia in a tertiary inpatient paediatric population","volume":"50","author":"Ota","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of healthcare associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.02566-12","article-title":"Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011","volume":"51","author":"Asmundsdottir","year":"2013","journal-title":"J. Clin. Microbiol"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Risum, M., Astvad, K., Johansen, H.K., Schonheyder, H.C., Rosenvinge, F., Knudsen, J.D., Hare, R., Datcu, R., Roder, B.L., and Antsupova, V.S. (2021). Update 2016\u20132018 of the nationwide Danish Fungaemia Surveillance Study: Epidemiologic changes in a 15-year perspective. J. Fungi, 7.","DOI":"10.3390\/jof7060491"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhin.2014.11.006","article-title":"Preventing invasive Candida infections. Where could we do better?","volume":"89","author":"Eggimann","year":"2015","journal-title":"J. Hosp. Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The changing epidemiology of invasive fungal infections","volume":"1508","author":"Enoch","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2141.2002.03414.x","article-title":"Effects of fluconazole prophylaxis on fungal blood cultures: An autopsy-based study involving 720 patients with haematological malignancy","volume":"117","author":"Kami","year":"2002","journal-title":"Br. J. Haemotol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: Results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011","volume":"55","author":"Cleaveland","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Poikonen, E., Lyytik\u00e4inen, O., Anttila, V.J., Koivula, I., Lumio, J., Kotilainen, P., Syrj\u00e4l\u00e4, H., and Ruutu, P. (2010). Secular trend in candidemia and the use of fluconazole in Finland, 2004\u20132007. BMC Infect. Dis., 10.","DOI":"10.1186\/1471-2334-10-312"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/313450","article-title":"The epidemiology of candidemia in two United States cities: Results of a population based active surveillance","volume":"29","author":"Kao","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/INF.0b013e318275612e","article-title":"The epidemiology of neonatal and pediatric candidemia in England and Wales, 2000\u20132009","volume":"32","author":"Oeser","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/myc.12349","article-title":"Epidemiology of candidemia in a tertiary care university hospital: 10-year experience with 381 candidemia episodes between 2001 and 2010","volume":"58","author":"Alp","year":"2015","journal-title":"Mycoses"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/510677","article-title":"Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts","volume":"44","author":"Segal","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: Trends in emergency department visits for suspected opioid overdoses\u2014United States, July 2016\u2013September 2017","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/JCM.40.9.3489-3492.2002","article-title":"Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland","volume":"40","author":"Asmundsdottir","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/myc.12535","article-title":"Differences in epidemiology of candidemia in the Nordic countries\u2014What is to blame?","volume":"60","author":"Hesstvedt","year":"2017","journal-title":"Mycoses"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/JCM.00029-06","article-title":"Candidemia in Norway (1991\u20132003): Results from a nationwide study","volume":"44","author":"Sandven","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3201\/eid0908.030069","article-title":"Candidemia in Finland, 1995\u20131999","volume":"9","author":"Poikonen","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"E218","DOI":"10.1111\/1469-0691.12111","article-title":"Candidemia in Sweden: A nationwide prospective observational study","volume":"19","author":"Ericsson","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01811-10","article-title":"National surveillance of fungemia in Denmark (2004\u20132009)","volume":"49","author":"Arendrup","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1111\/1469-0691.12212","article-title":"Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: Data from a nationwide fungaemia surveillance programme","volume":"19","author":"Arendrup","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/CCM.0000000000000746","article-title":"Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: Data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime","volume":"43","author":"Jensen","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Disease Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ben-Ami, R. (2018). Treatment of invasive candidiasis: A narrative review. J. Fungi, 4.","DOI":"10.3390\/jof4030097"},{"key":"ref_64","first-page":"161","article-title":"Organisation of antibiotic amphotericin B in model lipid membranes: A mini review","volume":"8","author":"Gruszecki","year":"2003","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/319211","article-title":"Mortality and cost of acute renal failure associated with amphotericin B therapy","volume":"32","author":"Bates","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","article-title":"Amphotericin B-induced nephrotoxicity: A review","volume":"12","author":"Fanos","year":"2000","journal-title":"J. Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM199903113401004","article-title":"Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"340","author":"Walsh","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/517642","article-title":"Life-threatening adverse event after amphotericin B lipid complex treatment in a patient treated previously with amphotericin B deoxycholate","volume":"26","author":"Garmendia","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/376634","article-title":"Amphotericin B: Time for a new \u201cgold standard\u201d","volume":"37","author":"Saravolatz","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/49.suppl_1.31","article-title":"Overview of the lipid formulations of amphotericin B","volume":"49","author":"Dupont","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/bj2660475","article-title":"Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans","volume":"266","author":"Hitchcock","year":"1990","journal-title":"Biochem. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/513663","article-title":"The epidemiology of hematogenous candidiasis caused by different Candida species","volume":"24","author":"Anaissie","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Dennin","year":"2003","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0966-842X(03)00117-3","article-title":"Antifungal agents: Mechanisms of action","volume":"11","author":"Odds","year":"2003","journal-title":"Trends Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/AAC.00262-08","article-title":"A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility","volume":"52","author":"Katiyar","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","article-title":"Resistance to echinocandin-class antifungal drugs","volume":"10","author":"Perlin","year":"2007","journal-title":"Drug Resist. Update"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/CMR.8.4.462","article-title":"New and emerging yeast pathogens","volume":"8","author":"Hazen","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","article-title":"Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus","volume":"42","author":"Pfaller","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/0002-9343(91)90349-3","article-title":"Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989","volume":"91","author":"Banerjee","year":"1991","journal-title":"Am. J. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2010.08.013","article-title":"Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: Application of new CLSI clinical breakpoints and epidemiologic cut-off values to characterise resistance in the SENTRY Antimicrobial Surveillance Program (2009)","volume":"69","author":"Pfaller","year":"2011","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JCM.00609-11","article-title":"Quantification of Candida CFU in initial positive blood cultures","volume":"49","author":"Pfeiffer","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/JCM.42.1.115-118.2004","article-title":"Direct comparison of the BACTEC 9240 and BacT\/Alert 3D automated blood culture systems for Candida growth detection","volume":"42","author":"Horvath","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/JCM.41.10.4714-4717.2003","article-title":"Detection of simulated candidemia by the BACTEC 9240 system with plus aerobic\/F and anaerobic\/F blood culture bottles","volume":"41","author":"Horvath","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.idc.2015.10.013","article-title":"Invasive candidiasis","volume":"30","author":"McCarty","year":"2016","journal-title":"Infect. Dis. Clin. North Am."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.tp.0000173771.47698.7b","article-title":"Candida glabrata fungemia in transplant patient receiving voriconazole after fluconazole","volume":"80","author":"Alexander","year":"2005","journal-title":"Transplantation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/003655401750065544","article-title":"Candidemia before and during the fluconazole era: Prevalence, type of species and approach to treatment in a tertiary care community hospital","volume":"33","author":"Baran","year":"2001","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AAC.49.11.4555-4560.2005","article-title":"Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: A case-case-control study","volume":"49","author":"Lin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicentre study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/513661","article-title":"The contribution of fluconazole to the changing epidemiology of invasive candidal infections","volume":"24","author":"White","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/1469-0691.12578","article-title":"Neonatal invasive fungal infection in England 2004\u20132010","volume":"20","author":"Oeser","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1086\/520277","article-title":"Emergence of Candida parapsilosis as the predominant species causing candidemia in children","volume":"26","author":"Levy","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1128\/JCM.40.7.2363-2369.2002","article-title":"Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit","volume":"40","author":"Lupetti","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/jcm.32.2.452-456.1994","article-title":"Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis","volume":"32","author":"Branchini","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1128\/JCM.42.10.4468-4472.2004","article-title":"Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital","volume":"42","author":"Clark","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/497138","article-title":"The changing face of fungal infections in healthcare settings","volume":"41","author":"Fridkin","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/JCM.44.5.1681-1685.2006","article-title":"Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002\u20132003","volume":"44","author":"Almirante","year":"2006","journal-title":"J. Clin. Microbiol"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/323812","article-title":"Risk factors for Candida tropicalis fungemia in patients with cancer","volume":"33","author":"Kontoyiannis","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogenic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","article-title":"Antifungal susceptibility patterns of a global collection of fungal isolates: Results of the SENTRY Antifungal Surveillance Program (2013)","volume":"85","author":"Castanheira","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/jcm.24.4.581-584.1986","article-title":"Increased incidence of fungemia caused by Candida krusei","volume":"24","author":"Merz","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/ijmm.IJMM_20_112","article-title":"Candidemia in a tertiary care centre of developing country: Monitoring possible change in spectrum of agents and antifungal susceptibility","volume":"38","author":"Kaur","year":"2020","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13756-020-00798-3","article-title":"A seven-year surveillance study of the epidemiology, antifungal susceptibility, risk factors and mortality of candidemia among paediatric and adult inpatients in a tertiary teaching hospital in China","volume":"9","author":"Zeng","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Zeng, Z., Tiang, G., Ding, Y., Yang, K., Liu, J., and Deng, J. (2019). Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4588-9"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13756-019-0534-2","article-title":"Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: A retrospective study from 2011\u20132017 in a teaching hospital in China","volume":"8","author":"Xiao","year":"2019","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Boonslip, S., Homkaew, A., Phumisantiphong, U., Nutalai, D., and Wongsuk, T. (2021). Species distribution, antifungal susceptibility and molecular epidemiology of candida species causing candidemia in a tertiary care hospital in Bangkok, Thailand. J. Fungi, 7.","DOI":"10.3390\/jof7070577"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"903","DOI":"10.47665\/tb.37.4.903","article-title":"Distribution of candidemia in a Malaysian tertiary care hospital revealed predominance of Candida parapsilosis","volume":"37","author":"Yamin","year":"2020","journal-title":"Trop. Biomed."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"O245","DOI":"10.1111\/1469-0691.12380","article-title":"Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain","volume":"20","author":"Padilla","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s15010-015-0845-z","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010\u20132014","volume":"44","author":"Barchiesi","year":"2016","journal-title":"Infection"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I.N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M.E., Thompson, L., and Sifuentes-Osornio, J. (2013). Epidemiology of candidemia in Latin America: A laboratory-based survey. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059373"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in Candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991\u20132000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"ofab471","DOI":"10.1093\/ofid\/ofab471","article-title":"Trends of the epidemiology of candidemia in Switzerland: A 15-year FUNGINOS survey","volume":"8","author":"Adam","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cmi.2015.06.008","article-title":"Twenty-two years of candidemia surveillance: Results from a Norwegian national study","volume":"21","author":"Hesstvedt","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1111\/j.1439-0507.2011.02027.x","article-title":"Epidemiology and management of candidemia\u2014A retrospective, multicentre study in five hospitals in the UK","volume":"54","author":"Chalmers","year":"2011","journal-title":"Mycoses"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"101210","DOI":"10.1016\/j.mycmed.2021.101210","article-title":"Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality","volume":"32","author":"Vannini","year":"2022","journal-title":"J. Mycol. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13613-020-00755-8","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: A single-centre retrospective 10-year analysis","volume":"10","author":"Schroeder","year":"2020","journal-title":"Ann. Intensive Care"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jac\/dkp251","article-title":"Incidence of candidemia and relationship with fluconazole use in an intensive care unit","volume":"64","author":"Bassetti","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Rodriguez, L., Bustamante, B., Huaroto, L., Agurto, C., Illescas, R., Ramirez, R., Diaz, A., and Hidalgo, J. (2017). A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175172"},{"key":"ref_121","first-page":"e10928","article-title":"Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of Sao Paulo state, Brazil. Braz","volume":"54","author":"Rodrigues","year":"2021","journal-title":"J. Med. Biol. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1128\/CMR.3.1.32","article-title":"Laboratory diagnosis of invasive candidiasis","volume":"3","author":"Jones","year":"1990","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_123","first-page":"65","article-title":"Laboratory diagnosis of invasive candidiasis","volume":"43","author":"Ellepola","year":"2005","journal-title":"J. Microbiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13054-016-1324-3","article-title":"Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions","volume":"20","author":"Leon","year":"2016","journal-title":"Crit. Care"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QCO.0000000000000594","article-title":"Rapid diagnosis of invasive candidiasis: Ready for prime-time?","volume":"32","author":"Clancy","year":"2019","journal-title":"Curr. Opin, Infect. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Clancy, C.J., and Nguyen, M.H. (2018). Non-culture diagnostics for invasive candidiasis: Promise and unintended consequences. J. Fungi, 4.","DOI":"10.3390\/jof4010027"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Clancy, C.J., Shields, R.K., and Nguyen, M.H. (2016). Invasive candidiasis in various patient populations: Incorporating non-culture diagnostic tests into rational management strategies. J Fungi, 2.","DOI":"10.3390\/jof2010010"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/cid\/cis200","article-title":"Performance of Candida real-time polymerase chain reaction, \u03b2-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis","volume":"54","author":"Nguyen","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID guideline for the diagnosis of Candida diseases 2012: Diagnostic procedures","volume":"18","author":"Verweij","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/159.3.495","article-title":"Candida antigen latex test for detection of invasive candidiasis in immunocompromised patients","volume":"159","author":"Ness","year":"1989","journal-title":"J. Infect. Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0025-6196(12)65791-7","article-title":"Quantitative blood cultures in candidemia","volume":"66","author":"Telenti","year":"1991","journal-title":"Mayo Clin. Proc."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e00471-18","DOI":"10.1128\/JCM.00471-18","article-title":"In vitro evaluation of BacT\/Alert FA blood culture bottles and T2 Candida assay for detection of Candida in the presence of antifungals","volume":"56","author":"Beyda","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/02681219180000581","article-title":"Sabouraud(\u2019s) agar","volume":"29","author":"Odds","year":"1991","journal-title":"J. Med. Vet. Mycol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1128\/jcm.32.8.1923-1929.1994","article-title":"CHROMagar Candida, a new differential isolation medium for presumptive isolation of clinically important Candida species","volume":"32","author":"Odds","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1128\/JCM.41.6.2629-2632.2003","article-title":"Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida","volume":"41","author":"Horvath","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0732-8893(96)00063-6","article-title":"Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance","volume":"24","author":"Bernal","year":"1996","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1128\/JCM.40.12.4768-4770.2002","article-title":"Persistence of pigment production by yeast isolates grown on CHROMagar Candida medium","volume":"40","author":"Hospenthal","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0732-8893(98)00096-0","article-title":"Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species","volume":"32","author":"Powell","year":"1998","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/jcm.34.1.58-61.1996","article-title":"Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata","volume":"34","author":"Pfaller","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-5-1","article-title":"Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida","volume":"5","author":"Hospenthal","year":"2006","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/14787210.2014.919853","article-title":"Undiagnosed invasive candidiasis: Incorporating non-culture diagnostics into rational prophylactic and pre-emptive antifungal strategies","volume":"12","author":"Clancy","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00148581-200709050-00001","article-title":"Current issues in pediatric medication adherence","volume":"9","author":"Matsui","year":"2007","journal-title":"Paediatr. Drugs"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Monday, L.M., Acosta, T.P., and Alangaden, G. (2021). T2 Candida for the diagnosis and management of invasive candida infections. J. Fungi, 7.","DOI":"10.3390\/jof7030178"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"115509","DOI":"10.1016\/j.diagmicrobio.2021.115509","article-title":"Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients","volume":"101","author":"Diez","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0213-005X(04)73039-6","article-title":"Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis","volume":"22","author":"Moragues","year":"2004","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4939-6515-1_18","article-title":"T2 Magnetic Resonance for fungal diagnosis","volume":"1508","author":"Zervou","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.diagmicrobio.2013.07.007","article-title":"Comparison of the T2Dx instrument with T2 Candida assay and automated blood culture in the detection of Candida species using seeded blood samples","volume":"77","author":"Beyda","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/JCM.02018-07","article-title":"Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis","volume":"46","author":"Clancy","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10158782.2009.11441337","article-title":"What\u2019s new in diagnostics? Fungitell\u00ae: 1,3 beta-D glucan assay","volume":"24","author":"Budhavari","year":"2009","journal-title":"South Afr. Epidemiol. Infect."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/cc9365","article-title":"The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: Recommendations from the Third European Conference on Infections in Leukemia","volume":"14","author":"Mikulska","year":"2010","journal-title":"Crit. Care"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccm.2009.02.012","article-title":"Approach to the diagnosis of invasive aspergillosis and candidiasis","volume":"30","author":"Wheat","year":"2009","journal-title":"Clin. Chest Med."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Hanson, K.E., Pfeiffer, C.D., Lease, E.D., Balch, A.H., Zaas, A.K., Perfect, J.R., and Alexander, B.D. (2012). \u03b2-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: A randomized pilot study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042282"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/cid\/ciu080","article-title":"Prophylactic echinocandin: Is there a subgroup of intensive care unit patients who benefit?","volume":"58","author":"Muldoon","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nchembio.2007.24","article-title":"Targeting virulence: A new paradigm for antimicrobial therapy","volume":"3","author":"Clatworthy","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drudis.2008.11.013","article-title":"Targeting virulence: A new paradigm for antifungals","volume":"14","author":"Gauwerky","year":"2009","journal-title":"Drug Discov. Today"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e01991-17","DOI":"10.1128\/mBio.01991-17","article-title":"Development of anti-virulence approaches for candidiasis via a novel series of small molecule inhibitors of Candida albicans filamentation","volume":"8","author":"Romo","year":"2017","journal-title":"mBio"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/EC.05085-11","article-title":"Coevolution of morphology and virulence in Candida species","volume":"10","author":"Thompson","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"15012","DOI":"10.1038\/npjbiofilms.2015.12","article-title":"A novel small molecule inhibitor of biofilm formation, filamentation and virulence with low potential for the development of resistance","volume":"1","author":"Pierce","year":"2015","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/EC.05030-11","article-title":"Modulation of morphogenesis in Candida albicans by various small molecules","volume":"10","author":"Shareck","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s40588-015-0015-1","article-title":"Update on Antifungal Drug Resistance","volume":"2","author":"Perlin","year":"2015","journal-title":"Curr. Clin. Microbiol. Rep."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: Prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/6\/1208\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:30:31Z","timestamp":1760139031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/6\/1208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,13]]},"references-count":161,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["microorganisms10061208"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms10061208","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,13]]}}}